Literature DB >> 8878326

Steroid hormones, the menopause, sexuality and well-being of women.

E H Cawood1, J Bancroft.   

Abstract

One hundred and forty-one women, aged 40-60 years, recruited from the community were assessed with an initial interview, plus four interviews at intervals of 1 week and blood samples. The objective was to investigate the determinants of sexuality and well-being in this sample. Measures included interview ratings of sexual function, Frenken Sexual Experience Scales and the Multiple Affect Adjective Check List. Determinants evaluated, using multiple regression analysis, included age, menopausal status, BMI, smoking, ovarian steroids and adrenal androgens. None of the hormonal parameters significantly predicted measures of sexuality; the most important predictors were other aspects of the sexual relationship, sexual attitudes and measures of well-being. The best predictor of both well-being and depression was tiredness. The only hormone positively related to well-being was dehydroepiandrosterone (DHEA).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878326     DOI: 10.1017/s0033291700035261

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  20 in total

1.  Transdermal testosterone replacement to improve women's sexual functioning.

Authors:  K D Louie
Journal:  Can Fam Physician       Date:  2001-08       Impact factor: 3.275

2.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 3.  Aging and sexuality.

Authors:  C M Meston
Journal:  West J Med       Date:  1997-10

Review 4.  DHEA and the skeleton (through the ages).

Authors:  C M Gordon; J Glowacki; M S LeBoff
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

Review 5.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

6.  Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Sarah Brockwell; John F Randolph; Shunhua Shen; Virginia S Cain; Marcia Ory; Gail A Greendale
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

7.  Pharmacologically induced hypogonadism and sexual function in healthy young women and men.

Authors:  Peter J Schmidt; Emma M Steinberg; Paula Palladino Negro; Nazli Haq; Carolyn Gibson; David R Rubinow
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

8.  Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.

Authors:  Sophia N Kalantaridou; Vien H Vanderhoof; Karim A Calis; Emily C Corrigan; James F Troendle; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2007-10-25       Impact factor: 7.329

Review 9.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

10.  Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT).

Authors:  Holly N Thomas; Gregory W Evans; Dan R Berlowitz; Glenn M Chertow; Molly B Conroy; Capri G Foy; Stephen P Glasser; Cora E Lewis; William T Riley; Laurie Russell; Olubunmi Williams; Rachel Hess
Journal:  J Hypertens       Date:  2016-06       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.